Table 1.
Route of infection | Mouse strain | Sex | Age | Bacterial strain | LD50 or ID50 (CFU) | Duration of observation | Reference |
---|---|---|---|---|---|---|---|
i.p. | BALB/c | N.I. | N.I. | A2 | 19 | N.I. | Taweechaisupapong et al. (2005) |
i.p. | BALB/c | Female | 6–8 weeks | A2 | 20 | 30 days | Srilunchang et al. (2009) |
i.p. | C57BL/6 | Female | 6–8 weeks | A2 | 3 × 102 | 30 days | Srilunchang et al. (2009) |
i.v. | BALB/c | Mix | 6–10 weeks | TGH | 4 | 10 days | Leakey et al. (1998) |
i.v. | C57BL/6 | Mix | 6–10 weeks | TGH | 2.5 × 104 | 10 days | Leakey et al. (1998) |
i.p. | TO | Female | 10–12 weeks | 708a | >5 × 105 | 65 days | Santanirand et al. (1999) |
i.p. | 129/SvEv | N.I. | N.I. | 708a | 1 × 102 | 65 days | Santanirand et al. (1999) |
i.p. | BALB/c | N.I. | N.I. | 708a | 2.31 × 103 | N.I. | Titball et al. (2008) |
i.p., Intraperitoneal; i.v., intravenous; N.I., not indicated..